ArticlePharmaceuticals (Basel, Switzerland)2026

Development and Systematic Evaluation of a Low-Irritation PFD-AIS Formulation for Pulmonary-Targeted Therapy.

Xinze Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.